WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer

Abstract The WW domain is composed of 38 to 40 semi-conserved amino acids shared with structural, regulatory, and signaling proteins. WW domain-binding protein 2 (WBP2), as a binding partner of WW domain protein, interacts with several WW-domain-containing proteins, such as Yes kinase-associated pro...

Full description

Bibliographic Details
Main Authors: Shuai Chen, Han Wang, Yu-Fan Huang, Ming-Li Li, Jiang-Hong Cheng, Peng Hu, Chuan-Hui Lu, Ya Zhang, Na Liu, Chi-Meng Tzeng, Zhi-Ming Zhang
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Molecular Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12943-017-0693-9
_version_ 1818256718500462592
author Shuai Chen
Han Wang
Yu-Fan Huang
Ming-Li Li
Jiang-Hong Cheng
Peng Hu
Chuan-Hui Lu
Ya Zhang
Na Liu
Chi-Meng Tzeng
Zhi-Ming Zhang
author_facet Shuai Chen
Han Wang
Yu-Fan Huang
Ming-Li Li
Jiang-Hong Cheng
Peng Hu
Chuan-Hui Lu
Ya Zhang
Na Liu
Chi-Meng Tzeng
Zhi-Ming Zhang
author_sort Shuai Chen
collection DOAJ
description Abstract The WW domain is composed of 38 to 40 semi-conserved amino acids shared with structural, regulatory, and signaling proteins. WW domain-binding protein 2 (WBP2), as a binding partner of WW domain protein, interacts with several WW-domain-containing proteins, such as Yes kinase-associated protein (Yap), paired box gene 8 (Pax8), WW-domain-containing transcription regulator protein 1 (TAZ), and WW-domain-containing oxidoreductase (WWOX) through its PPxY motifs within C-terminal region, and further triggers the downstream signaling pathway in vitro and in vivo. Studies have confirmed that phosphorylated form of WBP2 can move into nuclei and activate the transcription of estrogen receptor (ER) and progesterone receptor (PR), whose expression were the indicators of breast cancer development, indicating that WBP2 may participate in the progression of breast cancer. Both overexpression of WBP2 and activation of tyrosine phosphorylation upregulate the signal cascades in the cross-regulation of the Wnt and ER signaling pathways in breast cancer. Following the binding of WBP2 to the WW domain region of TAZ which can accelerate migration, invasion and is required for the transformed phenotypes of breast cancer cells, the transformation of epithelial to mesenchymal of MCF10A is activated, suggesting that WBP2 is a key player in regulating cell migration. When WBP2 binds with WWOX, a tumor suppressor, ER transactivation and tumor growth can be suppressed. Thus, WBP2 may serve as a molecular on/off switch that controls the crosstalk between E2, WWOX, Wnt, TAZ, and other oncogenic signaling pathways. This review interprets the relationship between WBP2 and breast cancer, and provides comprehensive views about the function of WBP2 in the regulation of the pathogenesis of breast cancer and endocrine therapy in breast cancer treatment.
first_indexed 2024-12-12T17:32:13Z
format Article
id doaj.art-f52adfa4f9d9443ead3124b5fde75862
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-12T17:32:13Z
publishDate 2017-07-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-f52adfa4f9d9443ead3124b5fde758622022-12-22T00:17:20ZengBMCMolecular Cancer1476-45982017-07-011611910.1186/s12943-017-0693-9WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancerShuai Chen0Han Wang1Yu-Fan Huang2Ming-Li Li3Jiang-Hong Cheng4Peng Hu5Chuan-Hui Lu6Ya Zhang7Na Liu8Chi-Meng Tzeng9Zhi-Ming Zhang10Department of Breast Surgery, The First Affiliated Hospital of Xiamen UniversityTranslational Medicine Research Center (TMRC), School of Pharmaceutical Science, Xiamen UniversityDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen UniversityTranslational Medicine Research Center (TMRC), School of Pharmaceutical Science, Xiamen UniversityTranslational Medicine Research Center (TMRC), School of Pharmaceutical Science, Xiamen UniversityTranslational Medicine Research Center (TMRC), School of Pharmaceutical Science, Xiamen UniversityDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen UniversityTranslational Medicine Research Center (TMRC), School of Pharmaceutical Science, Xiamen UniversityDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen UniversityTranslational Medicine Research Center (TMRC), School of Pharmaceutical Science, Xiamen UniversityDepartment of Breast Surgery, The First Affiliated Hospital of Xiamen UniversityAbstract The WW domain is composed of 38 to 40 semi-conserved amino acids shared with structural, regulatory, and signaling proteins. WW domain-binding protein 2 (WBP2), as a binding partner of WW domain protein, interacts with several WW-domain-containing proteins, such as Yes kinase-associated protein (Yap), paired box gene 8 (Pax8), WW-domain-containing transcription regulator protein 1 (TAZ), and WW-domain-containing oxidoreductase (WWOX) through its PPxY motifs within C-terminal region, and further triggers the downstream signaling pathway in vitro and in vivo. Studies have confirmed that phosphorylated form of WBP2 can move into nuclei and activate the transcription of estrogen receptor (ER) and progesterone receptor (PR), whose expression were the indicators of breast cancer development, indicating that WBP2 may participate in the progression of breast cancer. Both overexpression of WBP2 and activation of tyrosine phosphorylation upregulate the signal cascades in the cross-regulation of the Wnt and ER signaling pathways in breast cancer. Following the binding of WBP2 to the WW domain region of TAZ which can accelerate migration, invasion and is required for the transformed phenotypes of breast cancer cells, the transformation of epithelial to mesenchymal of MCF10A is activated, suggesting that WBP2 is a key player in regulating cell migration. When WBP2 binds with WWOX, a tumor suppressor, ER transactivation and tumor growth can be suppressed. Thus, WBP2 may serve as a molecular on/off switch that controls the crosstalk between E2, WWOX, Wnt, TAZ, and other oncogenic signaling pathways. This review interprets the relationship between WBP2 and breast cancer, and provides comprehensive views about the function of WBP2 in the regulation of the pathogenesis of breast cancer and endocrine therapy in breast cancer treatment.http://link.springer.com/article/10.1186/s12943-017-0693-9WW domainWBP2Breast cancerEstrogen receptorSignaling pathwayTyrosine kinase
spellingShingle Shuai Chen
Han Wang
Yu-Fan Huang
Ming-Li Li
Jiang-Hong Cheng
Peng Hu
Chuan-Hui Lu
Ya Zhang
Na Liu
Chi-Meng Tzeng
Zhi-Ming Zhang
WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
Molecular Cancer
WW domain
WBP2
Breast cancer
Estrogen receptor
Signaling pathway
Tyrosine kinase
title WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
title_full WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
title_fullStr WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
title_full_unstemmed WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
title_short WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
title_sort ww domain binding protein 2 an adaptor protein closely linked to the development of breast cancer
topic WW domain
WBP2
Breast cancer
Estrogen receptor
Signaling pathway
Tyrosine kinase
url http://link.springer.com/article/10.1186/s12943-017-0693-9
work_keys_str_mv AT shuaichen wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT hanwang wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT yufanhuang wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT minglili wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT jianghongcheng wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT penghu wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT chuanhuilu wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT yazhang wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT naliu wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT chimengtzeng wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer
AT zhimingzhang wwdomainbindingprotein2anadaptorproteincloselylinkedtothedevelopmentofbreastcancer